Cargando…
P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL)
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428478/ http://dx.doi.org/10.1097/01.HS9.0000968244.94930.74 |
_version_ | 1785090479741730816 |
---|---|
author | Kempter, Tamara Richter-Pechanska, Paulina Michel, Katarzyna Rausch, Tobias Erarslan-Uysal, Büşra Eckert, Cornelia Zimmermann, Martin Stanulla, Martin Schrappe, Martin Cario, Gunnar Kirschner-Schwabe, Renate Koehrer, Stefan Korbel, Jan Kunz, Joachim Kulozik, Andreas E |
author_facet | Kempter, Tamara Richter-Pechanska, Paulina Michel, Katarzyna Rausch, Tobias Erarslan-Uysal, Büşra Eckert, Cornelia Zimmermann, Martin Stanulla, Martin Schrappe, Martin Cario, Gunnar Kirschner-Schwabe, Renate Koehrer, Stefan Korbel, Jan Kunz, Joachim Kulozik, Andreas E |
author_sort | Kempter, Tamara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428478 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104284782023-08-17 P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) Kempter, Tamara Richter-Pechanska, Paulina Michel, Katarzyna Rausch, Tobias Erarslan-Uysal, Büşra Eckert, Cornelia Zimmermann, Martin Stanulla, Martin Schrappe, Martin Cario, Gunnar Kirschner-Schwabe, Renate Koehrer, Stefan Korbel, Jan Kunz, Joachim Kulozik, Andreas E Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428478/ http://dx.doi.org/10.1097/01.HS9.0000968244.94930.74 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Kempter, Tamara Richter-Pechanska, Paulina Michel, Katarzyna Rausch, Tobias Erarslan-Uysal, Büşra Eckert, Cornelia Zimmermann, Martin Stanulla, Martin Schrappe, Martin Cario, Gunnar Kirschner-Schwabe, Renate Koehrer, Stefan Korbel, Jan Kunz, Joachim Kulozik, Andreas E P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) |
title | P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) |
title_full | P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) |
title_fullStr | P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) |
title_full_unstemmed | P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) |
title_short | P333: SUBCLONAL AND CLONAL VARIANTS IN TP53 AND KRAS COMBINED WITH POOR TREATMENT RESPONSE IDENTIFY A SUBGROUP OF ULTRA-HIGH-RISK PATIENTS OF PEDIATRIC T-LYMPHOBLASTIC LEUKEMIA (T-ALL) |
title_sort | p333: subclonal and clonal variants in tp53 and kras combined with poor treatment response identify a subgroup of ultra-high-risk patients of pediatric t-lymphoblastic leukemia (t-all) |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428478/ http://dx.doi.org/10.1097/01.HS9.0000968244.94930.74 |
work_keys_str_mv | AT kemptertamara p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT richterpechanskapaulina p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT michelkatarzyna p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT rauschtobias p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT erarslanuysalbusra p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT eckertcornelia p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT zimmermannmartin p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT stanullamartin p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT schrappemartin p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT cariogunnar p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT kirschnerschwaberenate p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT koehrerstefan p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT korbeljan p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT kunzjoachim p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall AT kulozikandrease p333subclonalandclonalvariantsintp53andkrascombinedwithpoortreatmentresponseidentifyasubgroupofultrahighriskpatientsofpediatrictlymphoblasticleukemiatall |